ArticleFrontiers in medicine2021

Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide.

Danny Alon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.